[Postoperative course of craniopharyngioma].
D000293:Adolescent; D000309:Adrenal Insufficiency / Q000209:etiology; D000328:Adult; D000568:Amenorrhea / Q000150:complications; D001932:Brain Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D003072:Cognition Disorders / Q000150:complications; D003397:Craniopharyngioma / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D003919:Diabetes Insipidus / Q000150:complications / Q000188:drug therapy; D004700:Endocrine System Diseases / Q000150:complications; D005260:Female; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications; D007022:Hypotension / Q000150:complications; D008297:Male; D009461:Neurologic Manifestations / Q000150:complications; D011183:Postoperative Complications; D011655:Pulmonary Embolism / Q000209:etiology; D012964:Sodium / Q000097:blood; D013610:Tachycardia / Q000150:complications; D014786:Vision Disorders / Q000150:complications
D012964:Sodium; D006854:Hydrocortisone